Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

Nature Medicine

Volumn 5, Issue 2, 1999, Pages 194-203

  Baba, Timothy W ^a,b,c   Liska, Vladimir ^a,b   Khimani, Anis H ^a,b   Ray, Nancy B ^a,b   Dailey, Peter J ^d   Penninck, Dominique ^e   Bronson, Rod ^e   Greene, Michael F ^f   McClure, Harold M ^g   Martin, Louis N ^h   Ruprecht, Ruth M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e TUFTS UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; DRUG DESIGN; DRUG INDUCED DISEASE; GENE DELETION; INTRAVENOUS DRUG ADMINISTRATION; MACACA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

AGING; AMNIOTIC FLUID; ANIMALS; DISEASE PROGRESSION; FEMALE; GENE PRODUCTS, NEF; GENE PRODUCTS, VPR; IMMUNITY, MUCOSAL; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SAIDS VACCINES; SEQUENCE DELETION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, ATTENUATED;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032905068     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/5557     Document Type: Article

References (42)

1. Letvin, N.L. Vaccines against human immunodeficiency virus - Progress and prospects. N. Engl. J. Med. 329, 1400-1405 (1993).
2. Letvin, N.L. & King, N.W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3, 1023-1040 (1990).
3. Davison-Fairburn, B. et al. Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during middle, and late gestation. J. Med. Primatol. 19,381-393 (1990).
4. Ochs, H.D. et al. Maternal-fetal transmission of SIV in macaques: Disseminated adenovirus infection in an offspring with congenital SIV infection. J. Med. Primatol. 20, 193-200 (1991).
5. Amedee, A.M. et al. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J. Virol. 69, 7982-7990 (1995).
6. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941 (1992).
7. Whatmore, A.M. et al. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69, 5117-5123 (1995).
8. Almond, N. et al. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345, 1342-1344 (1995).
9. Norley, S., Beer, B., Binninger-Schninzel, D., Cosma, C. & Kurth, R. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology 219, 195-205 (1996).
10. Wyand, M.S., Manson, K.H., Garcia-Moll, M., Montefiori, D. & Desrosiers, R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70, 3724-3733 (1996).
11. Clements, J.E. et al. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69, 2737-2744 (1995).
12. rd. et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
13. Gibbs, J.S., Regier, D. A. & Desrosiers, R.C. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses 10, 607-616 (1994).
14. Baba, T.W. et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825 (1995).
15. Wyand, M.S., Manson K.H., Lackner, A.A. & Desrosiers, R.C. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nature Med. 3, 32-36 (1997).
16. Liska, V., Lerche, N.W. & Ruprecht, R.M. Simultaneous defection of simian retro-virus type D serotypes 1, 2, and 3 by polymerase chain reaction. AIDS Res. Hum. Retroviruses 13, 433-437 (1997).
17. Connor, R.I. et al. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72, 7501-7509 (1998).
18. Binley, J. M. et al. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71, 2799-2809 (1997).
19. Zhang, J.-Y. et al. Simian immunodeficiency virus/Delta-induced disease in rhesus monkeys: Relation of antibody response and antigenemia. J. Infect. Dis. 158, 1277-1286 (1988).
20. Kindt, T.J., Hirsch, V.M., Johnson, P.R. & Sawasdikosol, S. Animal models for acquired immunodeficiency syndrome. Adv. Immunol. 52, 425-474 (1992).
21. Pantaleo, G. et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358 (1993).
22. Embretson, J. et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362 (1993).
23. Rosenberg, Y.J. et al. Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques. AIDS Res. Hum. Retroviruses 10, 863-872 (1994).
24. Baskin G.B. et al. Lentivirus-induced pulmonary lesions in rhesus monkeys (Macaco mulatta) infected with simian immunodeficiency virus. Vet. Pathol. 28, 506-513 (1991).
25. Kirchoff F., Kestler H.W. III & Desrosiers, R.C. Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in the absence of an intact nef gene. J. Virol. 68, 2031-2037 (1994).
26. Baba, T.W. et al. Attenuated retrovirus vaccines and AIDS. Science 270, 1220-1222 (1995).
27. Ruprecht, R.M., Baba, T.W., Rasmussen, R., Hu, Y. & Sharma, P. L. Murine and simian retrovirus models: The threshold hypothesis. AIDS 10 (suppl A), S33-S40 (1996).
28. Garcia, J.V. & Miller, D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511 (1991).
29. Aiken, C., Konner, J., Landau, N.R., Lenburg, M.E. & Trono, D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864 (1994).
30. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier F. & Heard, J.M. Endocytosis of major histocompatibility complex class 1 molecules is induced by the HIV-1 Nef protein. Nature Med. 2, 338-342 (1996).
31. Miller, M.D., Warmerdam, M.T., Gaston, I., Greene, W.C. & Feinberg, M.B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113 (1994).
32. Spina, C.A., Kwoh, T.J., Chowers, M.Y., Guatelli, J.C. & Richman, D.D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123 (1994).
33. Fazely, F., Haseltine, W.A., Rodger, R.F. & Ruprecht, R.M. Simian immunodeficiency virus infection via amniotic fluid: A model to study fetal immunopathogenesis and prophylaxis. J. Acq. Immune Defic. Syndr. 6, 107-114 (1993).
34. Desrosiers, R.C. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine. AIDS Res. Hum. Retroviruses 10, 331-332 (1994).
35. Sabin, A. B. Oral poliovirus vaccine: History of its development and use and current challenge to eliminate poliomyelitis from the world. J. Infect. Dis. 151, 420-436 (1985).
36. Liska, V., Fultz, P.N., Su, L. & Ruprecht, R.M. Detection of simian T cell leukemia virus type I infection in seronegative macaques. AIDS Res. Hum. Retrovirusrs 13, 1147-1153 (1997).
37. Baba, T.W. et al. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res. Hum. Retroviruses 10, 351-357 (1994).
38. Baba T.W. et al. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 272, 1486-1489 (1996).
39. Tsai, C.-C. et al. Effects of (R)-9-(2-phosphonylmethoxypropyl) adenine monotherapy on chronic SIV infection in macaques. AIDS Res. Hum. Retroviruses 13, 707-712 (1997).
40. Fox, C.H. & Cottler-Fox, M.H. in Current Protocols in Immunology, (eds. Coligan, J., Kruisbeek, A., Margulies, D., Shevach, E., & Stober, W.)(Wiley, New York, 1993).
41. Marx, P.A. et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med. 2, 1084-1089 (1996).
42. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41 (numder RR-17), 1-19 (1992).